Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Luke N. Redlon
Institution:
University of Illinois Chicago
Observed institutions:
Van Andel Institute,
University of Illinois Chicago
ORCID:
0009-0005-9199-8084
Observed ORCID:
0009-0005-9199-8084
OpenAlex ID:
A5098489198
NF1 deficiency drives metabolic reprogramming in ER+ breast cancer
2024
·
Rachel (Rae) J. House
, Elizabeth A. Tovar
, et al.
·
Molecular Metabolism
·
15
Epigenetic regulation of individual components of combined hepatocellular-cholangiocarcinoma
2025
·
Kyle M. Schachtschneider
, Luke N. Redlon
, et al.
·
PLoS ONE
·
1
PDF
Circulating Biomarkers for Interventional Oncology: Current Status and Future Direction
2026
·
Ron C. Gaba
, Wali Badar
, et al.
·
CardioVascular and Interventional Radiology
PDF
Animal Models for Interventional Oncology Research: Overview and Considerations in the Era of New Approach Methodologies
2026
·
Ron C. Gaba
, Wali Badar
, et al.
·
Journal of Vascular and Interventional Radiology
Modeling liver cancer molecular and histological features by CRISPR editing of porcine hepatocytes
2026
·
Lobna Elkhadragy
, Olayinka G. David
, et al.
·
JHEP Reports
Abstract 6497: Modeling HCC molecular and histological features by CRISPR editing of primary hepatocytes
2025
·
Lobna Elkhadragy
, Olayinka G. David
, et al.
·
Cancer Research
Show more works
View as search
Works count:
6
Citation count:
16
H-index:
1
I10-index:
1
Year
Topic
Type